Body mass index (BMI) Influences the Salutary Effects of Metformin on Survival After Lobectomy for Stage I NSCLC

INTRODUCTION: Metformin, a common medication used in the treatment of Diabetes Mellitus is known to have anti-cancer effects. We hypothesized that the salutary effect of metformin on the survival of patients with stage I NSCLC is influenced by body mass index (BMI). METHODS: Patients undergoing lobe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Yendamuri, Sai, Barbi, Joseph, Pabla, Sarabjot, Petrucci, Cara, Punnanitinont, Achamaporn, Nesline, Mary, Glenn, Sean T., Depietro, Paul, Papanicalou-Sengos, Antonios, Morrison, Carl, Dy, Grace K., Elkin, Peter L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386563/
https://ncbi.nlm.nih.gov/pubmed/31398539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.07.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados